Application no. and date | 12723132.2 (espacenet) (Federated) (European Patent Register), 20120511 | Patent/reg. no. and date | DK/EP 2707017, 20150916 | Publication date | 20140319 | Priority no. and date | EP 11166120, 20110513, EP 12163637, 20120410 | EP pub. no. and date |
EP 2707017 20140319 | Effective date | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50 65929 Frankfurt am Main, DE | Applicant ref. no. | Sanofi DE DE2011/107-EP-EPT | Inventor | SILVESTRE, Louise, c/o Sanofi Département Brevets 54 rue La Boétie
F-75008 Paris, FR, MIOSSEC, Patrick, c/o Sanofi Département Brevets 54 rue La Boétie
F-75008 Paris, FR, RUUS, Peter, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE, PINQUIER, Jean-Louis, c/o Sanofi Département Brevets 54 rue La Boétie
F-75008 Paris, FR, HINCELIN-MERY, Agnes, c/o Sanofi Département Brevets 54 rue La Boétie
F-75008 Paris, FR | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/155 (2006.01) , A61K 38/26 (2006.01) , A61P 3/10 (2006.01) | Title | LIXISENATID OG METFORMIN TIL BEHANDLING AF DIABETES TYPE 2 | Int. application no. | EP2012058747 | Int. publication no. | WO2012156298 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|